FMmeds Tirzepatide Review: Cost, a Cleared Warning-Letter Claim & Honest Verdict (2026)

Before anything else, a correction: an earlier version of this review left an unconfirmed FDA warning-letter claim standing against FMmeds. That claim is withdrawn — there is no FDA warning letter on record for this company, and the section below sets out how that was established.

The warning-letter claim, checked and cleared

On 7 August 2026 FDA's complete warning-letter index was paged in full — all 3,651 rows — and matched offline on the company column, the column FDA itself files a letter under, rather than by fulltext search, which matches letter bodies and whose zeroes prove nothing. FMmeds does not appear in it, under that name, under "FM meds", or under its named 503A pharmacy partner Manifest Pharmacy. SkinnyRx's own February 2026 letter returned in that same pass as a positive control, which is what makes the zero a result rather than a search that quietly failed. To be exact about what this establishes: as of 7 August 2026, FDA's own warning-letter database holds no warning letter on file for this company. It is not a verdict on FMmeds in any other respect. The same check cleared Fierce Health elsewhere on this site, and both corrections are published here rather than quietly deleted, because a reader who saw the earlier wording is owed the outcome.

Live verification found a client-side-rendered shell

This review also attempted to independently confirm FMmeds's current pricing directly against fmmeds.com. The page loaded, but its static HTML carries only a title and meta description — the actual content is built client-side in JavaScript, the same pattern seen on other providers reviewed on this site. Every figure below was last verified on July 26, 2026.

What FMmeds is

FMmeds is a Manhattan Beach-based DTC telehealth platform, selling compounded semaglutide and tirzepatide co-formulated with vitamin B12. It discloses its operating LLC and a full Manhattan Beach, CA address, and names a 503A pharmacy partner, Manifest Pharmacy (Greer, SC) — genuine transparency signals, independent of the unresolved warning-letter claim.

What FMmeds costs

Standard pricing is $265/month for all doses, dropping to an aggressive $95/month for semaglutide and $145/month for tirzepatide on a 12-month plan — flat across every dose strength, with no dose-escalation surcharge.

The brand-vs-compounded question

FMmeds dispenses compounded medication only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

FMmeds's real strengths is a disclosed operating LLC and full address, a named 503A pharmacy partner, aggressive 12-month pricing, flat pricing across all doses, and all-50-states-plus-DC coverage stated in the Terms. The trade-offs: the LegitScript certification's specific ID isn't shown, the clinical network isn't separately named, and this review's own attempt to verify pricing live was blocked by client-side rendering. What is no longer a trade-off is the regulatory claim: no FDA warning letter is on record for this company, checked against FDA's complete index on the company column. As with any GLP-1 program, confirm current pricing before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

FMmeds's disclosed legal entity, named pharmacy, and aggressive 12-month pricing are genuine positives and the regulatory claim this site once left hanging over the company is cleared: no such letter exists in FDA's index. What is left is ordinary diligence — current pricing could not be verified live, since the site renders client-side, so confirm it before you commit. For two providers that do have a letter on record, and where this review says so plainly, compare Belle Health or SkinnyRx. See our best tirzepatide providers ranking for the full field.